Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) (Q73164612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

B Pitt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Segal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F A Martinez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Meurers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A J Cowley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

I Thomas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P C Deedwania

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D E Ney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D B Snavely

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P I Chang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

747-752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Bradykinin-mediated effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Post marketing surveillance of captopril (for hypertension): a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Comparison of captopril and enalapril in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Chronic congestive heart failure. Where have we been? Where are we heading?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

The management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Distribution of left ventricular sympathetic afferents demonstrated by reflex responses to transmural myocardial ischemia and to intracoronary and epicardial bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901187-2

7 January 2021

10.1016/S0140-6736(97)01187-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9074572%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference